CXCL13, a B cell chemokine, and its receptor CXCR5 form a chemotactic axis whose aberrant activation drives B cell-mediated immune responses, thereby promoting inflammatory processes and endothelial injury, which are implicated in the pathophysiology of interstitial cystitis/bladder pain syndrome. Here, CXCL13 is linked to interstitial cystitis.